OptimizeRx Corporation (OPRX) Net income 2016–2025
OptimizeRx Corporation (OPRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$5.1MFY2025 · since FY2016: -$1.5M → $5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.1M | +125.5% |
| FY2024 | -$20.1M | -14.5% |
| FY2023 | -$17.6M | -53.6% |
| FY2022 | -$11.4M | -3125.4% |
| FY2021 | $378,079 | +117.1% |
| FY2020 | -$2.2M | +29.8% |
| FY2019 | -$3.1M | -1488.4% |
| FY2018 | $226,344 | +110.8% |
| FY2017 | -$2.1M | -36.7% |
| FY2016 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OPRX financial trends
OPRX RevenueOPRX Net marginOPRX Gross profitOPRX Gross marginOPRX Operating incomeOPRX Operating marginOPRX Operating cash flowOPRX Free cash flowOPRX Capital expendituresOPRX Return on equityOPRX Stock buybacksOPRX Dividends paidOPRX Total assetsOPRX Total liabilitiesOPRX Shareholders’ equityOPRX overview →